Track the Takeda Pharmaceutical Company Limited share price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €58.5bn. The latest transaction was reported on 10 September 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Nicola Greenway. Every trade is free.
17
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,435 of 29,064 companies
56.9
score / 100
Value
79
Quality
35
FCF yld·
Earn yld·
EV/EBITDA6.8x
ROE-2.3%
Gross mgn65%
Net mgn-3.4%
Debt/EBITDA6.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.